European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Forecast · Health, medical equipment and medicines

Upcoming blood products tenders in Spain

In the next 6 months we expect 15 blood products tenders in Spain from 15 buyers, 9 of them with high confidence. Most are expected in November 2026 (8). The forecast is computed daily from public data: buyers that tender the same purchase every year, contracts that are ending and grants for works and equipment.

This is a forecast, not an announcement. We estimate these tenders from public data: the buyers' earlier tenders, the end dates of their contracts and the grants they received. A buyer may publish later, differently or not at all — the buyer's own notices are what counts. Methodology.

Expected tenders
15
Buyers
15
High confidence
9

Expected tenders

ExpectedBuyerWhatWhy we expect itConfidence
now – Feb 2027
contract ends
Hospital Universitario Principe de AsturiasBlood products and immunoglobulins
Hyqvia vial 20 g (100 mg/ml) 200 ml, Hyqvia vial 30 g (100 mg/ml) 300 ml e Hyqvia vial 5 g (100 mg/ml) 50 ml
Typical value: ≈ €83,000
The current contract with TAKEDA FARMACEUTICA ESPAÑA, S.A. ends on 13 March 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 03/2026
high
now – Feb 2027
contract ends
Dirección del Instituto Nacional de Gestión Sanitaria (INGESA)Blood products and immunoglobulins
Suministro de productos hemoderivados de uso terapéutico procedentes del fraccionamiento industrial del plasma humano proveniente del Sistema Nacional de Salud
Typical value: ≈ €8.1m
The current contract with INSTITUTO GRIFOLS, S.A. ends on 5 March 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 09/2024
medium
now – Jan 2027
contract ends
Hospital Universitario La PazBlood products and immunoglobulins
Suministro de medicamentos exclusivos: Inmunoglobulina Anti Timocítica Conejo (TIMOGLOBULINA IMTIX), Milrinona (COROTROPE)
Typical value: ≈ €170,000
The current contract with SANOFI AVENTIS, S.A. ends on 20 February 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 05/2026
high
now – Jan 2027
contract ends
Dirección General de la Mutual Midat Cyclops, Mutua Colaboradora con la Seguridad Social, nº 1Blood products and immunoglobulins
Suministro de tejido músculo esquelético para Clínica MC Madrid
Typical value: ≈ €37,000
The current contract with BANC DE SANG I TEIXITS ends on 10 February 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 02/2025
medium
now – Feb 2027
contract ends
Gerencia de la Fundación Marqués de ValdecillaBlood products and immunoglobulins
Contrato basado en el acuerdo marco del INGESA ((2024/049) para el suministro de productos hemoderivados de uso terapéutico procedentes del fraccionamiento industrial de plasma humano proveniente del sistema nacional de salud, con destino al Banco de Sangre y Tejidos de Cantabria / Fundación Marqués de Valdecilla. Fraccionamiento plasma FMV/BSTC/CB 01/2025.
Typical value: ≈ €1.3m
The current contract with INSTITUTO GRIFOLS, S.A. ends on 16 March 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 10/2025
high
now – Nov 2026
contract ends
Hospital Universitario Puerta de Hierro MajadahondaBlood products and immunoglobulins
SUMINISTRO DE ALBUMINA HUMANA 20%,
Typical value: ≈ €790,000
The current contract with GRIFOLS MOVACO, S.A. ends on 19 December 2026 (from its stated duration); no new tender has been published yet.
Earlier tenders: 12/2025
high
now – Jan 2027
contract ends
Entidad Pública del Banco de Sangre y Tejidos de AragónBlood products and immunoglobulins
Contrato basado en el ACUERDO MARCO DEL INGESA (2024/049) para el suministro de productos hemoderivados de uso terapéutico procedentes del fraccionamiento industrial de plasma humano proveniente del sistema nacional de salud, con destino a la Entidad Pública Aragonesa del Banco de Sangre y Tejidos
Typical value: ≈ €1.4m
The current contract with INSTITUTO GRIFOLS, S.A. ends on 26 February 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 03/2026
high
Nov 2026 – Apr 2027
contract ends
Institut Català d'Oncologia (ICO)Blood products and immunoglobulins
Subministrament de sèrums per a l'elaboració de citostàtics mitjançant la tecnologia APOTECA CHEMO de la farmàcia metropolitana per l'Institut Català d'Oncologia.
Typical value: ≈ €110,000
The current contract with BAXTER, SL ends on 28 May 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 05/2025
medium
Dec 2026 – May 2027
contract ends
Fundación Rioja SaludBlood products and immunoglobulins
Contrato basado en el Acuerdo Marco del INGESA (2024/049) para el suministro de productos hemoderivados elaborados a partir del plasma humano obtenido por el Centro de Transfusión Banco de Sangre de La Rioja. Fundación Rioja Salud
Typical value: ≈ €680,000
The current contract with INSTITUTO GRIFOLS, S.A. ends on 3 June 2027; no new tender has been published yet.
Earlier tenders: 06/2025
high
Jan – Jun 2027
contract ends
Gerencia de Atención Especializada de BurgosBlood products and immunoglobulins
Suministro de Inmunoglobulina G Humana intravenosa
Typical value: ≈ €1.8m
The current contract with CSL BEHRING, S.A. ends on 1 July 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 12/2025
medium
Jan – Jun 2027
contract ends
Institut Català d'Oncologia (ICO)Blood products and immunoglobulins
Subministrament de sèrums per a la elaboració de citostàtics mitjançant la tecnologia APOTECA CHEMO de la farmàcia metropolitana de l’Institut Català d’Oncologia
Typical value: ≈ €110,000
The current contract with BAXTER, S.L. ends on 6 July 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 07/2025
medium
Jan – Jun 2027
contract ends
Servicio Andaluz de SaludBlood products and immunoglobulins
4ª PRO 6º CBAM INSTITUTO GRIFOLS, SAAcuerdo Marco con una única empresa por el que se fijan las condiciones para el suministro de hemoderivados de uso terapéutico elaborados a partir del fraccionamiento industrial del plasma humano procedente de los Centros de transfusión, tejidos y células pertenecientes a la Red Andaluza de Medicina Transfusional, Tejidos y Células del Servicio Andaluz de Salud. AM 2308/2021
Typical value: ≈ €880,000
The current contract with INSTITUTO GRIFOLS, S.A. ends on 13 July 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 07/2026
high
Jan – Jun 2027
contract ends
OSAKIDETZA - Servicio Vasco de Salud -Director GeneralBlood products and immunoglobulins
Suministro de Albumina Humana (DOE)
Typical value: ≈ €730,000
The current contract with OCTAPHARMA, S.A. ends on 23 July 2027 (from its stated duration); no new tender has been published yet. The current contract with Ammon-Ra Librería, S.L. ends on 7 July 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 03/2026, 06/2026
high
Apr – Sep 2027
contract ends
Servicio Madrileño de Salud - Hospital Universitario 12 de OctubreBlood products and immunoglobulins
Suministro de Amiodarona, Aflibercept, Inmunoglobulina contra timocitos, Milrinona, medicamentos de distribución exclusiva de la firma “Sanofi Aventis, S.A." con destino al Servicio de Farmacia del Hospital Universitario 12 de Octubre
Typical value: ≈ €440,000
The current contract with SANOFI AVENTIS S.A. ends on 14 October 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 10/2026
medium
May – Sep 2027
contract ends
Dirección Gerencia de Atención Primaria de ToledoBlood products and immunoglobulins
P.A. 2026-0-7 Inmunoglobulina humana solución para perfusión
Typical value: ≈ €3.1m
The current contract with TAKEDA FARMACEUTICA ESPAÑA, S.A. ends on 29 October 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 07/2026
high

Expected by month

  • November 2026 8
  • December 2026 1
  • January 2027 4
  • April 2027 1
  • May 2027 1

In other countries

Published tenders

Questions and answers

Which blood products tenders are planned in Spain?
We expect 15 tenders from 15 buyers in the coming months. The next ones: Hospital Universitario Principe de Asturias — Blood products and immunoglobulins (now – Feb 2027); Dirección del Instituto Nacional de Gestión Sanitaria (INGESA) — Blood products and immunoglobulins (now – Feb 2027); Hospital Universitario La Paz — Blood products and immunoglobulins (now – Jan 2027).
When are blood products tenders published in Spain?
By the forecast, most in November 2026: 8.
How do you know a tender will be published?
We do not know for sure — it is a forecast from public data: the buyer published the same kind of tender in at least two consecutive years around the same date, its service or supply contract is ending, or it received a grant for works or equipment and has not tendered yet. Methodology
What does the confidence mean?
High: three years in a row within three weeks of the same date, or several signals at once. Medium: two years in a row or a wider window, an ending contract or a large grant. We do not show forecasts of low confidence.
Is this an official procurement plan?
No. Many buyers publish their own procurement plans and prior information notices — binding dates are only there and in the contract notices themselves.